About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
(C) 2024 MINKABU THE INFONOID, Inc.

Oncolys BioPharma Inc.(4588) Financial Results

4588
TSE Growth
Oncolys BioPharma Inc.
520
JPY
+14
(+2.77%)
Dec 23, 3:30 pm JST
3.34
USD
Dec 23, 1:00 am EST
Result
ー
PTS
outside of trading hours
519
Dec 23, 3:23 pm JST
Summary Chart Historical News Financial Result
Current Period Guidance
Annual
Result
Guidance History
Growth Rate
Profitability
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Dec, 2020 314 -1,674 -1,723 -2,095 -145.6 0 Feb 12, 2021 J-GAAP
Dec, 2021 642 -1,454 -1,500 -1,615 -95.5 0 Feb 10, 2022 J-GAAP
Dec, 2022 976 -1,204 -1,163 -1,148 -66.3 0 Feb 10, 2023 J-GAAP
Dec, 2023 63 -1,929 -1,913 -1,938 -108.9 0 Feb 9, 2024 J-GAAP
Dec, 2024 Guidance ー ー ー ー － 0 Feb 9, 2024 J-GAAP
YoY － － － － －
All-Time High
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 1,303 -140 28 37 854.8
Fiscal Year Dec, 2019 Dec, 2012 Dec, 2010 Dec, 2010 Dec, 2010
Second Half
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul - Dec, 2021 449 -821 -851 -965 -57.1 0 Feb 10, 2022 J-GAAP
Jul - Dec, 2022 550 -546 -573 -578 -33.4 0 Feb 10, 2023 J-GAAP
Jul - Dec, 2023 0 -1,029 -1,046 -1,070 -60.1 0 Feb 9, 2024 J-GAAP
Jul - Dec, 2024 Guidance ー ー ー ー － 0 Feb 9, 2024 J-GAAP
YoY － － － － －
Cash Flow
Annual
Fiscal Year Operating Profit Fee Cash Flow Operating Cash Flow Investing Cash Flow Financial Cash Flow Cash & Equivalents Cash Ratio Accounting Standards
Dec, 2021 -1,454 -1,741 -1,741 0 3,091 3,209 74.78 J-GAAP
Dec, 2022 -1,204 -1,697 -1,717 20 -113 1,466 55.32 J-GAAP
Dec, 2023 -1,929 -1,341 -1,336 -5 1,142 1,287 63.09 J-GAAP
Actual Performance and Financial Trends
Accumulated Results 3rd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Jan - Sep, 2022 784 -937 -854 -835 -48.2 ー Nov 4, 2022 J-GAAP
Jan - Sep, 2023 63 -1,311 -1,270 -1,272 -73.2 ー Nov 10, 2023 J-GAAP
Jan - Sep, 2024 31 -1,230 -1,243 -1,246 -59.6 ー Nov 8, 2024 J-GAAP
YoY -50.8% +6.2% +2.1% +2.0% +18.6%
Quarterly Results
Result
Growth Rate
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Oct - Dec, 2022 192 -267 -309 -313 -18.1 -139.1 Feb 10, 2023 J-GAAP
Jan - Mar, 2023 35 -325 -323 -323 -18.7 -928.6 May 12, 2023 J-GAAP
Apr - Jun, 2023 28 -575 -544 -545 -31.5 -2,053.6 Aug 4, 2023 J-GAAP
Jul - Sep, 2023 0 -411 -403 -404 -23.2 -Inf Nov 10, 2023 J-GAAP
Oct - Dec, 2023 0 -618 -643 -666 -37.4 -Inf Feb 9, 2024 J-GAAP
Jan - Mar, 2024 0 -378 -363 -364 -18.2 -Inf May 10, 2024 J-GAAP
Apr - Jun, 2024 31 -415 -389 -390 -19.1 -1,338.7 Aug 9, 2024 J-GAAP
Jul - Sep, 2024 0 -437 -491 -492 -23.5 -Inf Nov 8, 2024 J-GAAP
YoY － -6.3% -21.8% -21.8% -1.2%
All-Time High Quarterly Results
Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS
Record 663 89 88 87 6.4
Fiscal Year Dec, 2019 Jun, 2019 Jun, 2019 Jun, 2019 Jun, 2019
Key Balance Sheet Figures
Fiscal Year BPS Equity Ratio Total Asset Equity Retained Earnings Interest-Bearing Debt Ratio Announce Accounting Standards
Dec, 2021 206.86 83.6 4,291 3,586 -14,516 0.14 Feb 10, 2022 J-GAAP
Dec, 2022 124.20 81.2 2,650 2,151 -1,434 0.18 Feb 10, 2023 J-GAAP
Dec, 2023 74.35 71.5 2,040 1,459 -3,373 0.21 Feb 9, 2024 J-GAAP
Jan - Sep, 2024 ー 81.5 2,397 1,953 -4,619 0.17 Nov 8, 2024 J-GAAP